Production (Stage)
International Stem Cell Corporation
ISCO
$0.1667
$0.01258.11%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 2.13M | 2.45M | 2.18M | 2.33M | 2.13M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 2.13M | 2.45M | 2.18M | 2.33M | 2.13M |
Cost of Revenue | 992.00K | 990.00K | 974.00K | 913.00K | 887.00K |
Gross Profit | 1.14M | 1.46M | 1.21M | 1.42M | 1.24M |
SG&A Expenses | 1.17M | 1.64M | 1.11M | 1.26M | 1.24M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.34M | 2.40M | 2.27M | 2.18M | 2.31M |
Operating Income | -215.00K | 51.00K | -90.00K | 149.00K | -178.00K |
Income Before Tax | -256.00K | 11.00K | -125.00K | 119.00K | -214.00K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -256.00K | 11.00K | -125.00K | 119.00K | -214.00K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -256.00K | 11.00K | -125.00K | 119.00K | -214.00K |
EBIT | -215.00K | 51.00K | -90.00K | 149.00K | -178.00K |
EBITDA | -160.00K | 105.00K | -37.00K | 199.00K | -129.00K |
EPS Basic | -0.03 | 0.00 | -0.02 | 0.01 | -0.03 |
Normalized Basic EPS | -0.02 | 0.00 | -0.01 | 0.01 | -0.02 |
EPS Diluted | -0.03 | 0.00 | -0.02 | 0.01 | -0.03 |
Normalized Diluted EPS | -0.02 | 0.00 | -0.01 | 0.01 | -0.02 |
Average Basic Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
Average Diluted Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |